RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $197,200 | +28.9% | 20,000 | 0.0% | 0.13% | +17.5% |
| Q3 2023 | $153,000 | +2.4% | 20,000 | 0.0% | 0.11% | +3.6% |
| Q2 2023 | $149,400 | +12.0% | 20,000 | 0.0% | 0.11% | +4.8% |
| Q1 2023 | $133,400 | -19.9% | 20,000 | 0.0% | 0.10% | -21.6% |
| Q4 2022 | $166,600 | -21.8% | 20,000 | 0.0% | 0.13% | -33.3% |
| Q3 2022 | $213,000 | +9.2% | 20,000 | -16.7% | 0.20% | +9.8% |
| Q2 2022 | $195,000 | -49.6% | 24,000 | -55.6% | 0.18% | -45.0% |
| Q1 2022 | $387,000 | – | 54,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |